127 related articles for article (PubMed ID: 38316379)
1. Lithocholic acid-based oligomers as drug delivery candidates targeting model of lipid raft.
Wnętrzak A; Szymczuk D; Chachaj-Brekiesz A; Dynarowicz-Latka P; Lupa D; Lipiec EW; Laszuk P; Petelska AD; Markiewicz KH; Wilczewska AZ
Biochim Biophys Acta Biomembr; 2024 Mar; 1866(3):184294. PubMed ID: 38316379
[TBL] [Abstract][Full Text] [Related]
2. Monounsaturated PE does not phase-separate from the lipid raft molecules sphingomyelin and cholesterol: role for polyunsaturation?
Shaikh SR; Brzustowicz MR; Gustafson N; Stillwell W; Wassall SR
Biochemistry; 2002 Aug; 41(34):10593-602. PubMed ID: 12186543
[TBL] [Abstract][Full Text] [Related]
3. Designing a Useful Lipid Raft Model Membrane for Electrochemical and Surface Analytical Studies.
Zaborowska M; Dziubak D; Matyszewska D; Sek S; Bilewicz R
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576954
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol dynamics in membranes of raft composition: a molecular point of view from 2H and 31P solid-state NMR.
Aussenac F; Tavares M; Dufourc EJ
Biochemistry; 2003 Feb; 42(6):1383-90. PubMed ID: 12578350
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A distribution in cholesterol-sphingomyelin artificial membranes modeled as Langmuir monolayers.
Wnętrzak A; Makyła-Juzak K; Chachaj-Brekiesz A; Lipiec E; Romeu NV; Dynarowicz-Latka P
Colloids Surf B Biointerfaces; 2018 Jun; 166():286-294. PubMed ID: 29604571
[TBL] [Abstract][Full Text] [Related]
6. Studies on the interactions of anticancer drug - Minerval - with membrane lipids in binary and ternary Langmuir monolayers.
Węder K; Mach M; Hąc-Wydro K; Wydro P
Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2329-2336. PubMed ID: 29864405
[TBL] [Abstract][Full Text] [Related]
7. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: a comparative NMR, DSC, AFM, and detergent extraction study.
Shaikh SR; Dumaual AC; Castillo A; LoCascio D; Siddiqui RA; Stillwell W; Wassall SR
Biophys J; 2004 Sep; 87(3):1752-66. PubMed ID: 15345554
[TBL] [Abstract][Full Text] [Related]
8. Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy.
Geisse NA; Cover TL; Henderson RM; Edwardson JM
Biochem J; 2004 Aug; 381(Pt 3):911-7. PubMed ID: 15128269
[TBL] [Abstract][Full Text] [Related]
9. Lipid raft components cholesterol and sphingomyelin increase H+/OH- permeability of phosphatidylcholine membranes.
Gensure RH; Zeidel ML; Hill WG
Biochem J; 2006 Sep; 398(3):485-95. PubMed ID: 16706750
[TBL] [Abstract][Full Text] [Related]
10. Fluorinated cholesterol retains domain-forming activity in sphingomyelin bilayers.
Matsumori N; Okazaki H; Nomura K; Murata M
Chem Phys Lipids; 2011 Jul; 164(5):401-8. PubMed ID: 21664344
[TBL] [Abstract][Full Text] [Related]
11. X-ray grazing incidence diffraction and Langmuir monolayer studies of the interaction of beta-cyclodextrin with model lipid membranes.
Flasiński M; Broniatowski M; Majewski J; Dynarowicz-Łatka P
J Colloid Interface Sci; 2010 Aug; 348(2):511-21. PubMed ID: 20493495
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelin distribution in lipid rafts of artificial monolayer membranes visualized by Raman microscopy.
Ando J; Kinoshita M; Cui J; Yamakoshi H; Dodo K; Fujita K; Murata M; Sodeoka M
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4558-63. PubMed ID: 25825736
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic properties and characterization of proteoliposomes rich in microdomains carrying alkaline phosphatase.
Bolean M; Simão AM; Favarin BZ; Millán JL; Ciancaglini P
Biophys Chem; 2011 Oct; 158(2-3):111-8. PubMed ID: 21676530
[TBL] [Abstract][Full Text] [Related]
14. Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way - the Langmuir monolayer study.
Hąc-Wydro K; Dynarowicz-Łątka P; Wydro P; Bąk K
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):635-40. PubMed ID: 21862295
[TBL] [Abstract][Full Text] [Related]
15. Binding of a pleurotolysin ortholog from Pleurotus eryngii to sphingomyelin and cholesterol-rich membrane domains.
Bhat HB; Kishimoto T; Abe M; Makino A; Inaba T; Murate M; Dohmae N; Kurahashi A; Nishibori K; Fujimori F; Greimel P; Ishitsuka R; Kobayashi T
J Lipid Res; 2013 Oct; 54(10):2933-43. PubMed ID: 23918047
[TBL] [Abstract][Full Text] [Related]
16. Impact of sphingomyelin acyl chain (16:0 vs 24:1) on the interfacial properties of Langmuir monolayers: A PM-IRRAS study.
Vázquez RF; Daza Millone MA; Pavinatto FJ; Fanani ML; Oliveira ON; Vela ME; Maté SM
Colloids Surf B Biointerfaces; 2019 Jan; 173():549-556. PubMed ID: 30347381
[TBL] [Abstract][Full Text] [Related]
17. Anesthetics interacting with lipid rafts.
Bandeiras C; Serro AP; Luzyanin K; Fernandes A; Saramago B
Eur J Pharm Sci; 2013 Jan; 48(1-2):153-65. PubMed ID: 23142844
[TBL] [Abstract][Full Text] [Related]
18. Influence of 7α-hydroxycholesterol on sphingomyelin and sphingomyelin/phosphatidylcholine films - The Langmuir monolayer study complemented with theoretical calculations.
Wnętrzak A; Chachaj-Brekiesz A; Janikowska-Sagan M; Dynarowicz-Latka P
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):861-870. PubMed ID: 30716293
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid regulates the formation of lipid rafts: A unified view from experiment and simulation.
Wassall SR; Leng X; Canner SW; Pennington ER; Kinnun JJ; Cavazos AT; Dadoo S; Johnson D; Heberle FA; Katsaras J; Shaikh SR
Biochim Biophys Acta Biomembr; 2018 Oct; 1860(10):1985-1993. PubMed ID: 29730243
[TBL] [Abstract][Full Text] [Related]
20. Properties of Langmuir and solid supported lipid films with sphingomyelin.
Jurak M; Golabek M; Holysz L; Chibowski E
Adv Colloid Interface Sci; 2015 Aug; 222():385-97. PubMed ID: 24725646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
